Increased brain manganese (Mn) following inhalation can result from direct transport via olfactory neurons and blood delivery. Human health risk assessments for Mn should consider the relative importance of these pathways. The objective of this study was to develop a pharmacokinetic model describing the olfactory transport and blood delivery of Mn in rats following acute MnCl 2 or MnHPO 4 inhalation. Model compartments included the olfactory mucosa (OM), olfactory bulb, olfactory tract and tubercle, and striatum. Intercompartmental transport of Mn was described as ipsilateral, anterograde movement to deeper brain regions. Each compartment contained free and bound Mn and included blood influx and efflux. First-order rate constants were used to describe transport. Model parameters were estimated by comparing the model with published experimental data in rats exposed by inhalation to 54 MnCl 2 or 54 MnHPO 4 with both nostrils patent or one nostril occluded. The model-derived elimination rate constant from the OM was higher for the chloride salt (0.022 per hour) compared with the phosphate salt (0.011 per hour), consistent with their relative solubilities. Rate constants for Mn transport among the other compartments were similar for both Mn forms. Our results indicate that direct olfactory transport provided the majority of Mn tracer in the olfactory regions during the 21 days following exposure to 54 MnHPO 4 and 8 days following exposure to 54 MnCl 2 . Only a small fraction of Mn tracer from the tract and tubercle was predicted to be delivered to the striatum, 3 and 0.1% following 54 MnHPO 4 or 54 MnCl 2 exposure, respectively.
Increased brain manganese (Mn) following inhalation can result from direct transport via olfactory neurons and blood delivery. Human health risk assessments for Mn should consider the relative importance of these pathways. The objective of this study was to develop a pharmacokinetic model describing the olfactory transport and blood delivery of Mn in rats following acute MnCl 2 or MnHPO 4 inhalation. Model compartments included the olfactory mucosa (OM), olfactory bulb, olfactory tract and tubercle, and striatum. Intercompartmental transport of Mn was described as ipsilateral, anterograde movement to deeper brain regions. Each compartment contained free and bound Mn and included blood influx and efflux. First-order rate constants were used to describe transport. Model parameters were estimated by comparing the model with published experimental data in rats exposed by inhalation to 54 MnCl 2 or 54 MnHPO 4 with both nostrils patent or one nostril occluded. The model-derived elimination rate constant from the OM was higher for the chloride salt (0.022 per hour) compared with the phosphate salt (0.011 per hour), consistent with their relative solubilities. Rate constants for Mn transport among the other compartments were similar for both Mn forms. Our results indicate that direct olfactory transport provided the majority of Mn tracer in the olfactory regions during the 21 days following exposure to 54 MnHPO 4 and 8 days following exposure to 54 MnCl 2 . Only a small fraction of Mn tracer from the tract and tubercle was predicted to be delivered to the striatum, 3 and 0.1% following 54 MnHPO 4 or 54 MnCl 2 exposure, respectively. Key Words: manganese; olfactory transport; pharmacokinetic model.
Manganese (Mn) is an essential element that is a component of several enzymatic systems in the body including the metalloenzymes arginase, glutamine synthetase, phosphoenolpyruvate decarboxylase, and Mn superoxide dismutase. Mn is ubiquitous in the environment (0.1% of earth's crust), where it is found as a component of a variety of minerals including sulfides, oxides, carbonates, phosphates, silicates, and borates. Emissions of Mn into the environment can occur during mining, crushing, and smelting of ores during steel production, during manufacturing of Mn-containing products, and during use of Mn-containing products such as agricultural and garden applications of certain fertilizers and fungicides. Another source of Mn emission that recently has received increased scrutiny over concerns of potential health effects is the fuel additive methylcyclopentadienyl Mn tricarbonyl (MMT) (Davis, 1998; Kaiser et al., 2003) . Combustion of MMT in automobile engines results in the release of various Mncontaining compounds, mainly Mn sulfate, Mn phosphate, and Mn tetraoxide, into the environment. Because inhalation exposure has been shown to result in greater amounts of Mn reaching the brain than ingestion (Andersen et al., 1999) , the use of MMT has become a public health concern with a priority of determining the effects from exposure to ambient Mn. Chronic inhalation exposure to high concentrations of Mn in occupational settings has been shown to result in adverse neurological, respiratory, and reproductive effects (IPCS, 1999) . The majority of cases have been documented in miners (Pal et al., 1999) . The neurotoxic effects of Mn result in extrapyramidal symptoms resembling Parkinson disease, such as dystonia and severe gait disturbances. Although Mn is known to accumulate in the basal ganglia in humans, the mechanism of Mn neurotoxicity as well as the potential for Mn to cause neurotoxicity at lower, environmentally relevant concentrations is not known (Davis, 1999) . Concern over potential neurotoxic effects from inhalation of Mn from ambient air has lead to a need to quantitate the deposition of Mn in the brain and ascertain pharmacokinetic mechanisms involved in brain delivery.
A number of studies have investigated the uptake of Mn in animals from inhalation exposure to a variety of Mn compounds including less soluble forms such as Mn phosphate and Mn oxide and more soluble forms such as Mn chloride and Mn sulfate. In experimental animals following exposure to various forms of Mn, there were increases in Mn brain concentrations, which were form dependent, dose dependent, and region specific (Dorman et al. 2001a,b; Fechter et al., 2002; Normandin et al., 2002 Normandin et al., , 2004 Salehi et al., 2003; St-Pierre et al., 2001; Tapin et al., 2006; Vitarella et al., 2000) . Oftentimes, the brain region with the largest increase in concentration following Mn exposure was the olfactory bulb (OB). Both transport of Mn from the blood following Mn absorption in the lungs as well as direct olfactory transport can contribute to this accumulation (Dorman et al., 2006) . Tjälve et al. (1995 Tjälve et al. ( , 1996 was the first to demonstrate that Mn could be transported via olfactory receptor neurons after intranasal administration of Mn in pike and in rats. Although the exact mechanism of transport along olfactory neurons is not known, other researchers have noted olfactory neuronal transport of Mn into the brain (Brenneman et al., 2000; Cross et al., 2004; Dorman et al., 2002; Elder et al., 2006; Henriksson et al., 1999) . The acute inhalation studies by Dorman et al. (2002) with 54 MnHPO 4 , a poorly soluble salt, and by Brenneman et al. (2000) with 54 MnCl 2 , a more soluble salt, have attempted to quantify the relative contribution of blood delivery versus olfactory transport to various brain structures following inhalation exposures to Mn.
Although Dorman et al. (2002) and Brenneman et al. (2000) have demonstrated the relative differences qualitatively in various olfactory regions and the striatum from blood delivery versus olfactory transport of Mn, a quantitative estimate is needed that can be used in risk assessments to address Mn delivery to susceptible brain regions. A pharmacokinetic model describing the flux of Mn via the various pathways could be used to estimate the contributions via blood versus olfactory delivery, and such models eventually could be linked to a physiologically based pharmacokinetic model to describe whole-body distribution of Mn from oral and inhalation exposures. The objective of this article was to develop a pharmacokinetic model in the rat to describe the olfactory transport of Mn while accounting for blood delivery following acute inhalation exposures to Mn. The parameterized model was used to estimate the relative contribution of blood delivery versus olfactory transport in the rat.
MATERIALS AND METHODS
The transport model was built to evaluate published data sets for inhalation exposure of rats to Mn (Brenneman et al., 2000; Dorman et al., 2002) . The investigators measured time courses of 54 Mn in olfactory compartments on the left and right sides of the olfactory pathway including the olfactory mucosa (OM), OB, and olfactory tract and tubercle (OTT). The concentration of 54 Mn in the left and right striatum, which is part of the basal ganglia and includes the caudate nucleus and putamen, was also measured to provide information on Mn accumulation in more distal brain regions following inhalation exposure. The model simulated distribution of Mn via the olfactory neurons and the blood into each of the compartments. Brenneman et al. (2000) exposed CD rats by nose-only exposure to 54 MnCl 2 (0.54 mg Mn/m 3 ; mass median aerodynamic diameter (MMAD) 2.51 lm; specific activity 2.5 nCi/ng) for 90 min, and Dorman et al. (2002) exposed CD rats by nose-only exposure to 54 MnHPO 4 (0.39 mg Mn/m 3 ; MMAD 1.68 lm; specific activity 0.51 nCi/ng) for 90 min. In each experiment, one group was exposed with both nostrils patent, while a second group was exposed with the right nostril occluded. Thus, the developed model represented right and left sides of the head. Following exposure, the OM, OB, OTT, and striatum along with liver, kidney, and pancreas were collected at 0, 1, 3, 5, and 8 days in both experiments; the 54 MnHPO 4 study also collected samples on day 21. 54 Mn concentrations were measured in tissues by gamma spectrometry. For modeling comparisons, the measured 54 Mn concentrations were converted with the specific activity of Mn to total Mn concentrations (ng Mn/g) derived from the 54 Mn exposure in the tissues, hereafter referred to as Mn tracer. Statistically significant differences were seen in Mn tracer concentrations in the various olfactory tissues ipsilateral to the right and left OM, while the concentrations in the various regions were similar when both nostrils were patent. For
Experimental Data
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MnCl 2 experiments, the right and left striatum concentration of Mn tracer increased following the exposure in rats with both nostrils patent; however, the Mn tracer did not increase significantly in either the left or right striatum when the right nostril was plugged. For 54 MnHPO 4 , the right and left striatum concentrations increased following both the unplugged and the plugged exposures.
Model Structure
The anatomical regions of the olfactory system and brain (OM, OB, OTT, and striatum) that were experimentally evaluated and included in the model are shown in Figure 1 . The model (Figure 2 ) presumed that Mn would undergo axonal transport from the OM to the OB. Efferent projections from the OM are found within the superficial olfactory nerve layer of the OB. Multiple projections within the rat OB can contribute to Mn movement to the deeper granule cell layers involved in signal transduction to other sites (Shipley et al., 1995) . Serial transport of Mn from the OB to the OTTand then to the striatum (a structure containing basal ganglial targets for Mn neurotoxicity) was presumed to occur within our model.
In the model, each of the regions was represented by a homogeneous, wellmixed compartment. The olfactory transport of Mn tracer was ipsilateral from the OM to the OTT, assuming anterograde movement via primary or secondary FIG. 1. The sagittal view of the rat's head shows the areas of the OM, OB, OTT, and striatum (S), the regions included in the model. The relative volumes of the regions are given in Table 1 . olfactory neurons to the OTT. The Mn transported out of the OTT distributed partially to the ipsilateral striatum with the remainder distributed to the rest of brain. Previous studies have shown that anterograde movement of injected Mn occurs in the rat basal ganglia (Sloot and Gramsbergen, 1994) . Neuroimaging studies that followed the movement of Mn further confirm the anterograde movement of this metal (Murayama et al., 2006; Saleem et al., 2002) . In addition, neuroimaging studies performed in rats following intranasal administration of Mn are consistent with this model structure (Cross et al., 2004) .
Each side of the olfactory pathway and striatum were modeled the same except for the volume of the compartments in the model (Tables 1 and 2 ) and the initial concentration in the OM depending on whether the right nostril was plugged or unplugged during exposure (Figs. 4 and 5). The model had blood influx and efflux for each of the tissue compartments. Within each compartment, there existed both a free and bound pool of Mn tracer. Only the free pool of Mn tracer was available for either efflux to the blood or olfactory transport. This free pool does not necessarily represent divalent Mn but may also include other forms of Mn such as trivalent Mn, Mn citrate, Mn transferrin, or other forms of Mn, which have been shown to diffuse into the brain and other tissues (Aschner and Gannon, 1994; Crossgrove et al., 2003) . The bound Mn represented the sequestration of Mn which occurs in cells (Tiffany-Castiglioni and Qian, 2001) . The concentrations of Mn measured immediately following exposure to MnCl 2 (Brenneman et al., 2000) or MnHPO 4 (Dorman et al., 2002) were the initial compartment concentrations in the model. Henriksson et al. (1999) demonstrated saturable olfactory transport or influx across blood brain barrier, but the Mn concentrations used in those instillation studies were much higher than the inhalation studies used in this work. Henriksson et al. (1999) showed linear concentration-dependent transport at the concentrations observed by Brenneman et al. (2000) and Dorman et al. (2002) . Therefore, the rates of transport of Mn between tissue compartments and between bound and free pools were simply first order. The rates of influx and efflux from blood were modeled as first order to represent the active transport into the cells and the slow diffusion from the cells based on the results of Yokel et al. (2003) . Because the volume of the blood for each of the olfactory compartments is not known, the influx of Mn from the blood was estimated as a clearance rate, which is a product of the first-order rate constant and blood volume. Tables 1  and 2 contain the symbols used in the model and their description.
The mass balance in the OM was described by the equation:
where the clearance from the blood ðCl OM blood Þ was a product of the first-order influx rate constant ðk OM blood Þ and the blood volume in the mucosa compartment ðV
The mass balance for the OB was described by the following equation:
Schematic of the model used to describe olfactory transport and blood delivery of Mn to the left side of the brain ipsilateral to the OM in the left nasal cavity. The model structure for the right side was identical to the left side. Descriptions for the symbols are listed in Tables 1 and 2 . The compartments for the regions modeled included both a free and bound fraction. Only a fraction of Mn that exits the OTT enters the striatum. The remainder is distributed to the rest of the brain. The concentrations of tracer Mn measured immediately following exposure to 54 MnCl 2 (Brenneman et al., 2000) or 54 MnHPO 4 (Dorman et al., 2002) were the initial compartment concentrations in the model. The initial concentration and the absorption constant estimated for the blood in Table 3 most likely represented the Mn deposited in the lung that was absorbed systemically. Table 3 .
The clearance from the blood to the OB ðCl OB blood Þ was a product of the firstorder influx rate constant ðk OB blood Þ and the blood volume in the OB ðV OB blood Þ:
The mass balance for the OTT was described by the following equation:
The clearance from the blood to the OTT ðCl 
The mass balance in the striatum was described by the following equation in which only a fraction ðf S Þ of the Mn leaving the OTT was transported to the striatum:
The clearance from the blood to the striatum ðCl S blood Þ was a product of the first-order influx rate constant ðk S blood Þ and the blood volume in the striatum ðV S blood Þ:
The free concentration of Mn in all compartments (i ¼ OM, OB, OTT, or S) was described as
Model Parameters
Blood concentrations. Blood concentrations of 54 Mn were not measured in either the Brenneman et al. (2000) or Dorman et al. (2002) studies; however, 54 Mn concentrations in the kidney, liver, and pancreas following exposure were Unpublished results measured in CD rats used in Brenneman et al. (2000) study. Plugged and unplugged exposure data were averaged together because they were not significantly different.
b Not possible to estimate both constants for the binding; therefore, the rate constants for the bound to free Mn were set to a low rate to allow slow removal of Mn tracer from the bound compartment.
reported. The mean concentration in these three organs (Fig. 3 ) was used to represent the blood concentration. The concentration profile of Mn tracer versus time was used to estimate pharmacokinetic parameters for first-order absorption and elimination into a single compartment.
where
C h is the product of the fraction (F) of the administered dose (X h ) that is absorbed divided by the blood volume ðV blood Þ: Prism (Sigma Graphpad, Inc., San Diego, CA) was used to estimate the pharmacokinetic parameters for the blood. Prism uses the LevenbergMarquardt algorithm to minimize the sum-of-squares in the nonlinear regression. The resulting empirical equation was used to simulate the blood concentrations ðC blood Þ of Mn tracer following inhalation exposure.
Compartment volumes. Organ weights of the various olfactory tissue compartments were obtained from unpublished data from the Brenneman et al. (2000) and Dorman et al. (2002) studies. The weights measured on each day for the right and left sides were averaged together for both the plugged and unplugged exposures since they were not significantly different. The mean weights for each side of the olfactory system for the 54 MnCl 2 and 54 MnHPO 4 exposures were converted to volumes in the model assuming unit density (q ¼ 1 g/ml) and are shown in Tables 1 and 2 .
Rates of elimination, blood influx and efflux, and binding. The firstorder rate constant for the bound to free (k b:f ) could not be estimated from the data collected and was set to a low value (1 3 10 ÿ6 /h) that was similar to the efflux rate to represent slow removal from the bound fraction. Tables 1 and 2 . The objective criterion was maximization of the log likelihood function with the NelderMead optimization algorithm. The data were weighted assuming that the error in the data was proportional to the mean during the optimization of the parameters to better simulate concentrations at all time points. The parameters were estimated separately for the ) study. Plugged and unplugged exposure data were averaged together as they were not statistically different.
b Not possible to estimate both constants for the binding; therefore, the rate constants for the bound to free Mn were set to a low rate to allow slow removal of Mn tracer from the bound compartment. The optimized parameters were used to estimate the percentage of total Mn tracer in the compartments that was attributable to either olfactory transport or blood transport from the blood. The percentage was calculated from the mass of Mn tracer entering the compartment either via direct olfactory transport or from blood divided by the total mass from both the olfactory transport and blood that entered the compartment after exposure. For example, the percentage contribution of Mn tracer in the striatum from olfactory transport was given by:
Olfactory contribution ð%Þ ¼ 1003
The percentage contribution of Mn tracer in the striatum from transport from the blood was given by:
Blood contribution ð%Þ ¼ 1003
In both equations, t f is the time following exposure. The percentage contributions were calculated at the latest sampling time point for 54 MnCl 2 and 54 MnHPO 4 .
RESULTS
The blood concentrations of Mn tracer estimated from the mean of the liver, kidney, and pancreas concentrations differed between the 54 MnCl 2 and 54 MnHPO 4 exposures and between the plugged and unplugged exposures (Fig. 3) . These differences are reflected in the pharmacokinetic parameters used to describe the systemic blood concentration in the olfactory transport model (Table 3 ). The unplugged exposure resulted in higher amounts available for absorption into the blood and was likely due to increased minute ventilation rates (Dorman, unpublished data) . C h , the initial deposited concentration, was at least twofold higher for the unplugged exposure versus the plugged exposure for both 54 Brenneman et al. (2000) and Dorman et al. (2002) are shown in Figure 3 . As noted earlier, the tissue concentrations simulated with the pharmacokinetic constants given in Table 3 were used as the surrogate for blood concentrations in the olfactory transport model. Tables 1 and 2 for  54 MnCl 2  and 54 MnHPO 4 exposure, respectively. For both chemical forms, the striatum was the least accurate of the fits. For 54 MnCl 2 , the set of optimized parameters provided a better simulation of the plugged exposure than the unplugged (Tables 1 and 2 ). For the striatum, blood clearance was greater for 54 MnCl 2 . This was due to the model predicting less olfactory transport for the 54 MnCl 2 exposure. As seen in Tables 4 and 5 for the correlation coefficients among the model's parameters, f S and Cl S blood are highly correlated (ÿ 0.99 to ÿ 1.0). Therefore, either pathway (olfactory or blood) could be used to predict the observed increase in Mn tracer concentration in the striatum. Because striatal Mn tracer concentrations did not increase in either side in the plugged 54 MnCl 2 -exposed rats, but did in the unplugged animals, the optimization program attributed this to the difference in the blood concentrations and therefore efflux from the blood to the striatum. However, for plugged animals exposed to 54 MnHPO 4 , the left and right sides differed in the concentration profile with the left side increasing almost to the same concentration as in the unplugged exposures. Therefore, the increase in striatal Mn tracer concentrations was attributed to olfactory transport of 54 Mn as the blood concentrations between the plugged and unplugged exposure did not differ as much following this exposure. There was little efflux from the olfactory compartments or striatum into the blood for either 54 For 54 MnCl 2 , the majority of Mn tracer in the OB was contributed by direct olfactory transport from the OM for both sides of the olfactory system for both plugged and unplugged exposure. The percentage contributed by olfactory transport decreased in the OTT to approximately 70% for both sides of the olfactory system for the unplugged exposure. However, for the plugged exposure, the OTT on the occluded right side had a smaller contribution (40%) from olfactory transport from the OB. In the plugged exposure, Mn tracer in the right OB ipsilateral to the occluded nostril most likely represents Mn tracer transported from the blood to the OB, which would subsequently be transported via neurons to the OTT. Finally, in the striatum, the majority of the Mn tracer was transported from the blood for both the unplugged and the plugged exposures.
The percentage contribution following 54 MnHPO 4 exposure differed significantly from 54 MnCl 2 . For the OB, olfactory transport from the OM provided approximately the same percentage Mn tracer as blood delivery for the unplugged exposure. For the plugged exposures, on the left patent side, olfactory transport provided slightly more Mn tracer, whereas on the right occluded side, blood delivery provided slightly more Mn tracer. Unlike 54 MnCl 2 , the OTT for both the unplugged and plugged exposures received the largest percentage of Mn tracer due to direct olfactory transport on both the left and right sides. This is due to the comparable clearances from the OB to the OTT (1.4 3 10 ÿ3 ml/h) and from the blood into the OTT (1.6 3 10 ÿ3 ml/h) for the 54 MnHPO 4 exposures but higher concentrations of Mn tracer in the OB compared with the blood (peak concentrations of 40 ng/g compared with 7-9 ng/g, respectively). In addition, olfactory transport provided a larger percentage of Mn tracer to the striatum following 54 MnHPO 4 , again because the predicted clearance from the OTT and the OTT concentration were greater than the blood concentration and clearance to the striatum following 54 MnHPO 4 exposure. The correlations among estimated parameters for the olfactory transport model are listed in Tables 5 and 6 (Roels et al., 1997) . Both direct olfactory transport and blood delivery may contribute to Mn concentrations in the various olfactory regions and possibly other regions of the central nervous system following inhalation exposure (Brenneman et al., 2000; Cross et al., 2004; Dorman et al., 2002; Elder et al., 2006; Henriksson et al., 1999; Tjälve et al., 1996) . Tjälve et al. (1996) first raised concerns about Mn gaining access to more remote regions of the central nervous system via direct olfactory transport. They noted that tertiary olfactory connections originating in the anterior olfactory nucleus in the anterior portion of the olfactory peduncle may result in ipsilateral transport to the motor olfactory striatum (stria terminalis and nucleus accumbens septi) and the central amygdaloid nucleus.
Mn is known to cross the blood brain barrier from the systemic circulation and accumulate in various regions of the brain. MnCl 2 has been administered iv in rodents and primates to provide magnetic resonance imaging (MRI) images of the central nervous system (Aoki et al., 2004; Pautler and Estimated pharmacokinetic parameters for mean of liver, kidney, and pancreas concentration reported in Brenneman et al. (2000) . See text for equation and details. Equal to FX 0 =V b ;where X 0 is initial dose, F is fraction dose bioavailable for absorption, and V b is the blood volume. Koretsky, 2002) . With iv administration, the OB was the region with the greatest signal enhancement, while other regions of the olfactory system and the basal forebrain showed increased enhancement but to a lesser extent than the bulb (Aoki et al., 2004) .
Previous articles have demonstrated qualitatively that Mn delivery via the olfactory pathway to more distant regions in the brain such as the globus pallidus in nonhuman primates or the striatum in rats appears limited (Brenneman et al., 2000; Cross et al., 2004; Dorman et al., 2002; Elder et al., 2006; Henriksson et al., 1999; Tjälve et al., 1996) . However, neither the rates of transport via the olfactory system nor the relative contributions of blood delivery versus olfactory transport have been quantified. The purpose of this research was to develop a computational model describing the olfactory transport of Mn in the rat to provide estimates of the relative contribution of olfactory delivery versus blood delivery to brain regions of interest in Mn toxicity.
Consistent with the relative solubility of MnCl 2 and MnHPO 4 , the estimated rate of elimination of Mn tracer from the OM was twofold greater following 54 MnCl 2 exposure than 54 MnHPO 4 exposure. The rate constant in the olfactory epithelium is not only a reflection of the rate of movement of Mn along the olfactory neurons out of the epithelium but also represents the rates of dissolution of the particles into the mucosa layer, uptake of Mn into the olfactory neurons, and the movement of Mn along the primary neurons out of the epithelium into the OB. Therefore, the rate-limiting step will be the process that drives the value of the first-order rate constant for the elimination of Mn from the mucosa. At this time, the rate-limiting step is unknown but appears from our analysis to be dependent in part on Mn particle solubility.
The rate constants for transport of Mn tracer from the OB to the OTT and exiting the OTT were similar for both forms of Mn. This observation suggests that either the speciation of Mn is similar in the olfactory system following MnCl 2 and MnHPO 4 exposures or the rates at which various forms of Mn are transported along the olfactory neurons are similar. Both studies used a divalent form of Mn (Mn 2þ ). Neither the speciation of Mn in the various olfactory and brain regions nor the mechanism by which Mn is transported in the olfactory system is currently known. However, our model simulations revealed some differences in binding of Mn within the compartments and in its blood transport, suggesting that the speciation of Mn may differ following exposure to the chloride or phosphate form.
Inclusion of a bound fraction in each tissue compartment was necessary to slow Mn transport during the postexposure sampling period and is consistent with known tissue kinetics of Mn. Mn is incorporated into various cellular enzymes as well as sequestered in the mitochondria and other subcellular compartments in part to protect the cell from free concentrations of metals (Keen et al., 1999) . For the relatively shorttime domain modeled in this study, the binding of Mn was in essence irreversible as the tissue concentrations were not sensitive to k i b:f ; the rate constant for bound to free Mn. However, as the model is expanded to simulate multiple dosing and longer time domains, more accurate estimates of k i b:f likely will be needed to predict Mn distribution in the olfactory compartments and brain.
Different binding constants ðk i f :b Þ for the 54 MnCl 2 and 54 MnHPO 4 exposures were necessary to predict the amount of Mn tracer lost from the tissue compartments. The experimental data used in this study (Brenneman et al., 2000; Dorman et al., 2002) showed that the total combined amount of Mn tracer in the OM, OB, OTT, and striatum at 8 days after exposure was only 19% lower than the combined amount present immediately after exposure for 54 MnHPO 4 , whereas following 54 MnCl 2 it was 40% lower at 8 days after exposure. However, in the OM alone, the amounts lost following exposure to both forms were more similar at 8 days after exposure, 58 versus 68% for 54 MnHPO 4 and 54 MnCl 2 , respectively. Therefore, the difference in the combined amount lost from the OM, OB, OTT, and striatum was not solely due to lower solubility of the phosphate form in the mucosa.
Another model-predicted difference in Mn tracer transport following 54 MnCl 2 versus 54 MnHPO 4 exposure was influx of Mn tracer from the blood to the olfactory compartments and the striatum. For 54 MnCl 2 , the clearance from the blood (i.e., brain influx) was low and varied among the brain regions similar to Crossgrove et al. (2003) who measured variable influx of Mn tracer in different brain regions. For 54 MnHPO 4 , brain influx from the blood was higher in all the regions than that seen following 54 MnCl 2 exposure and was higher in the olfactory regions than the striatum. This observation is consistent with imaging studies performed following iv administration of Mn in which the OB (in addition to the choroid plexus and ventricles) have the earliest and highest signal intensities (Aoki et al., 2004) . One explanation for the difference in blood clearances between the two Mn forms could be different blood speciation of Mn. Crossgrove et al. (2003) showed dependence of brain region influx on the form of Mn in the blood. The speciation of Mn in the blood following inhalation has not been previously studied. Different rates of lung absorption of Mn into the circulation following MnHPO 4 versus MnCl 2 exposure could possibly result in different blood concentrations of the various forms of Mn and thus result in different distribution properties into and within the tissues.
The model predicted low transport efficiency via the olfactory pathway to the striatum following Mn exposure. Although this has been speculated from the previous work of Brenneman et al. (2000) and Dorman et al. (2002) , the model provided a quantitative estimate of 0.1% ( 54 MnCl2) or 3% ( 54 MnHPO 4 ) of Mn tracer eliminated from the OTT being transported directly to the striatum. Based on the concentrations of 54 Mn in the striatum, this mass flux represented only a minor contribution to the total Mn tracer (less than 10%) following 54 MnCl 2 exposure but likely represented approximately (Dorman et al., 2002) were similar to concentrations seen 8 days following 54 MnCl 2 exposure (Brenneman et al., 2000) (Figs. 4-7 ). The current model description of first-order transport of Mn from the blood to the striatum may not reflect the actual mechanism of Mn transport in vivo. MRI studies in rats following iv administration of MnCl 2 showed rapid enhancement in the choroid plexus and ventricles (Aoki et al., 2004) . One day thereafter the images showed enhancement of other brain regions. A more complete model could include this or other pathways by which Mn could reach the brain systemically. In addition, the description of the transport between free and bound Mn may be more complex than simple first-order transport.
Our model structure also represents a simplification of the neural circuits found in the rat olfactory and basal ganglial systems (Heimer et al., 1995; Shipley et al., 1995) . For example, the axons from the OB project in the olfactory tract to the anterior olfactory nucleus, the olfactory tubercle, the piriform cortex (primary olfactory cortex), the cortical nucleus of the amygdala, and the entorhinal area (Lledo et al., 2005) . Although greatly simplified, our model is consistent with Mn movement within the rat brain. Cross et al. (2002) mapped functional connections in the rat olfactory system with MRI of animals after unilateral intranasal delivery of this metal. They showed significant ipsilateral transport of Mn to the OB, lateral OTT, the piriform cortex in the lateral olfactory cortex, ventral pallidum, amygdala, and the anterior commissure. Cross' findings are also consistent with the tracer studies upon which our model was built (Brenneman et al., 2000; Dorman et al., 2002) . Other compounds including drugs, solvents, metals, and particulates have been shown to be transported directly via the olfactory neurons and trigeminal nerve to the brain (Bagger and Bechgaard, 2004; Brenneman et al., 2000; Chow et al., 2001; Ghantous et al., 1990; Illum, 2000; Larsson and Tjälve, 2000; Mathison et al., 1998; Oberdörster et al., 2004; Tjälve and Henrikkson, 1999; Wang et al., 1998) Graff et al. (2005) to describe the substrates' uptake by p-glycoprotein and distribution through the olfactory epithelium to the CNS of CF1 mice following intranasal instillation. The model was used to describe the time profile of radioactivity in serial sections taken from the brain. Graff et al. (2005) used a series of 20 homogeneous compartments with first-order absorption and diffusion to describe the rostral to caudal transport of the compounds. Blood delivery of the compounds was examined but not included in the final model for nasal administration. Our model was structured similarly with homogeneous compartments and first-order transport; however, our compartments represented discrete regions of the CNS instead of slices. In addition, blood delivery was necessary to describe Mn tracer absorbed from the lungs into the systemic blood and then distributed to the brain.
The model developed in this article for olfactory transport can be combined with a physiologically based pharmacokinetic model to estimate the whole-body distribution of Mn following inhalation or dietary exposure to various forms of Mn. This work is currently underway in our laboratory (Nong et al., 2007) . In addition, the model can be expanded to include predictions of the deposition of Mn particles during exposure, which will be useful for predicting chronic exposure scenarios and for extrapolation of the model to humans. Differences between the rodents and humans would include differences in the compartment volumes of the olfactory regions as they are significantly smaller in humans. Mn could be assumed to be transported via the olfactory neurons at the same rate in rats as in humans. The model could then help answer questions of potential contribution of olfactory transport for target tissue doses of Mn from chronic exposure to ambient air concentrations of various forms of Mn. 
